India · Delayed Price · Currency is INR Verve Therapeutics Statistics
Total Valuation
BOM:543945 has a market cap or net worth of INR 119.24 billion. The enterprise value is 117.52 billion.
| Market Cap | 119.24B |
| Enterprise Value | 117.52B |
Important Dates
The last earnings date was Friday, July 18, 2025.
| Earnings Date | Jul 18, 2025 |
| Ex-Dividend Date | Aug 22, 2025 |
Share Statistics
| Current Share Class | 56.65M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +1.22% |
| Shares Change (QoQ) | -0.25% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 16.41M |
Valuation Ratios
The trailing PE ratio is 91.92 and the forward PE ratio is 63.50.
| PE Ratio | 91.92 |
| Forward PE | 63.50 |
| PS Ratio | 9.17 |
| PB Ratio | 22.48 |
| P/TBV Ratio | 22.61 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 90.60 |
| EV / Sales | 9.03 |
| EV / EBITDA | 63.38 |
| EV / EBIT | 67.99 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | n/a |
| Interest Coverage | 40.26 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 22.26% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 35.94M |
| Profits Per Employee | 3.58M |
| Employee Count | 362 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:543945 has paid 454.49 million in taxes.
| Income Tax | 454.49M |
| Effective Tax Rate | 25.95% |
Stock Price Statistics
The stock price has decreased by -5.70% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -5.70% |
| 50-Day Moving Average | 1,915.11 |
| 200-Day Moving Average | 2,035.11 |
| Relative Strength Index (RSI) | 57.24 |
| Average Volume (20 Days) | 96,935 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:543945 had revenue of INR 13.01 billion and earned 1.30 billion in profits. Earnings per share was 22.91.
| Revenue | 13.01B |
| Gross Profit | 3.04B |
| Operating Income | 1.73B |
| Pretax Income | 1.75B |
| Net Income | 1.30B |
| EBITDA | 1.83B |
| EBIT | 1.73B |
| Earnings Per Share (EPS) | 22.91 |
Balance Sheet
The company has 1.80 billion in cash and 79.49 million in debt, giving a net cash position of 1.72 billion.
| Cash & Cash Equivalents | 1.80B |
| Total Debt | 79.49M |
| Net Cash | 1.72B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 5.30B |
| Book Value Per Share | 93.38 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 23.35%, with operating and profit margins of 13.29% and 9.97%.
| Gross Margin | 23.35% |
| Operating Margin | 13.29% |
| Pretax Margin | 13.46% |
| Profit Margin | 9.97% |
| EBITDA Margin | 14.07% |
| EBIT Margin | 13.29% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 2.50, which amounts to a dividend yield of 0.12%.
| Dividend Per Share | 2.50 |
| Dividend Yield | 0.12% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -1.22% |
| Shareholder Yield | -1.10% |
| Earnings Yield | 1.09% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |